Syros Pharmaceuticals

Syros Pharmaceuticals

  • Founded: 2013
  • Location: Cambridge, MA
  • Employee range: 50 - 200
  • Clinical stage: Clin3
  • Therapy area: Higher-risk myelodysplastic syndrome
  • Drug types: ONC
  • Lead product: Tamibarotene
  • Product link:
  • Funding: $130M stock Sep 2022; $90.5M stock Dec 2020

job board

Short description:

Gene Regulation Drug Discovery Platform

Drug notes:

Also Clin2 AML; SY-2101 Clin2 acute promyelocytic leukemia; SY-5609 Clin1/Clin2 pancreatic cancer, Clin1/Clin1b colorectal cancer (partner: Roche)

Long description:

Contact us to add description:


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy